Support Alert

Drug safety update: Gabapentin (Neurontin): risk of severe respiratory depression

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for Gabapentin which has been associated with a rare risk of severe respiratory depression even without concomitant opioid medicines.

Further details of the safety update, advice and recommendations are available on the MHRA website.
 

Loading...
Return To Top